ZURICH (Reuters) – Researchers studying Iceland's isolated genetic pool have identified a gene linked to rheumatoid arthritis that could represent a diagnostic and therapeutic target, the two companies running the project said on Thursday.
Mapping the gene was the latest accomplishment by Iceland's deCODE genetics and Swiss group Roche Holding AG.
"This marks a large step toward the development of molecular diagnostic tools that will improve the diagnosis of rheumatoid arthritis, as well as help recognize predisposition to the disease and enable the development of novel prevention regimes," the companies said in a statement.
"Early recognition of disease will allow timely and more aggressive treatment that may minimize serious joint damage," deCODE and Roche noted.
Hoping to uncover links between disease and genes, deCODE has been analyzing Iceland's unique composition, which experts say has remained stable since the Vikings arrived in the 9th and 10th centuries.
In September, deCODE and Roche said they had mapped two genes linked to obesity and clinical anxiety. The companies have already made progress in turning gene discoveries into treatments for schizophrenia and atherosclerosis.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!